Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Group 1 – Neurotypical adults (no neurological conditions):
- Adults aged 18 to 49
- Right-handed people
- Native English speakers
Group 2 – People with cerebellar lesions:
- Adults aged 18 or older
- Right-handed people
- Native English speakers
- People with a history of a stroke affecting the cerebellum (a part of the brain at the back of the skull)
Group 3 – General comparison group (matched to Group 2):
- Adults aged 18 or older
- Right-handed people
- Native English speakers
Who may not be able to join:
Group 1 – Neurotypical adults:
- People who have metal implants, pacemakers, neurostimulators, a metal-containing intrauterine device, or who have had shrapnel injuries, as these create safety risks in MRI scanners
- People with a history of a neurological or neurodegenerative disease, or a severe brain injury such as a stroke or serious head trauma
- People with hearing loss measured above 25 decibels at standard test frequencies (confirm with trial site)
- People who have been diagnosed with or treated for schizophrenia or another psychotic disorder
- People who have been diagnosed with or treated for a neurocognitive disorder such as dementia or delirium
- People with a severe, unmanaged, clinically diagnosed attention disorder
- People who have been diagnosed with or treated for a speech, language, or hearing disorder
- People with a head circumference greater than 60cm or a body weight greater than 300 pounds
- People with a history of severe claustrophobia (intense fear of enclosed spaces)
- People who are currently pregnant or possibly pregnant
Group 2 – People with cerebellar lesions:
- People who have metal implants, pacemakers, neurostimulators, a metal-containing intrauterine device, or who have had shrapnel injuries, as these create safety risks in MRI scanners
- People with a history of a neurological or neurodegenerative disease, or a severe brain injury other than stroke
- People with hearing loss measured above 50 decibels at standard test frequencies (confirm with trial site)
- People who have been diagnosed with or treated for schizophrenia or another psychotic disorder
- People who have been diagnosed with or treated for a neurocognitive disorder such as dementia or delirium
- People with a severe, unmanaged, clinically diagnosed attention disorder
- People with a head circumference greater than 60cm or a body weight greater than 300 pounds
- People with a history of severe claustrophobia
- People who are currently pregnant or possibly pregnant
Group 3 – General comparison group:
- People who have metal implants, pacemakers, neurostimulators, a metal-containing intrauterine device, or who have had shrapnel injuries, as these create safety risks in MRI scanners
- People with a history of a neurological or neurodegenerative disease, or a severe brain injury such as a stroke or serious head trauma
- People with hearing loss measured above 50 decibels at standard test frequencies (confirm with trial site)
- People who have been diagnosed with or treated for schizophrenia or another psychotic disorder
- People who have been diagnosed with or treated for a neurocognitive disorder such as dementia or delirium
- People with a severe, unmanaged, clinically diagnosed attention disorder
- People who have been diagnosed with or treated for a speech, language, or hearing disorder
- People with a head circumference greater than 60cm or a body weight greater than 300 pounds
- People with a history of severe claustrophobia
- People who are currently pregnant or possibly pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jason W Bohland, Ph.D., University of Pittsburgh
Phone: 412-383-3416
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Blood oxygenation level dependent (BOLD) responses to self vs. externally generated speech; BOLD responses related to pre-speech auditory modulation; EEG responses to self vs. externally generated speech; BOLD responses to induced auditory errors; BOLD responses during adaptation to auditory perturbations; BOLD responses during learning of non-speech auditory motor targets
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.